MitoKor
San Diego, CA, US· latest recorded location
MitoKor is named on 33 US grants and 24 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 33
- Published applications
- 24
- Inventors
- 40
- Granted in 2026 so far
- 0
- Most recent grant
- 31 May 2005
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 12 | 1 |
| 2002 | 3 | 8 |
| 2003 | 6 | 5 |
| 2004 | 2 | 9 |
| 2005 | 2 | 0 |
| 2006 | 0 | 1 |
By publication year.
Technology areas
Share of 57 documents
- A61KMedicines and medical preparations23
- A61PTherapeutic uses of medicines23
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms23
- C07DHeterocyclic compounds22
- C07KPeptides16
- C12NMicroorganisms or enzymes16
- C07CAcyclic or carbocyclic compounds14
- G01NInvestigating or analysing materials by determining their chemical or physical properties14
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or2
- A01KAnimal husbandry1
Recent patents
- Cobalt-porphyrin complexes and use thereof as an anti-obesity agent31 May 2005US 6,900,197 B2
- Method of targeting conjugate molecules to mitochondria15 Mar 2005US 6,867,197 B1
- Screening assays using intramitochondrial calcium26 Oct 2004US 6,808,873 B2
- Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions28 Sep 2004US 6,797,467 B1
- Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus25 Nov 2003US 6,653,094 B2
- Compounds for inhibiting insulin secretion and methods related thereto5 Jan 2006US 2006/0004062 A1
- Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor2 Dec 2004US 2004/0241801 A1
- Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto7 Oct 2004US 2004/0198777 A1
- Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto30 Sep 2004US 2004/0192740 A1
- Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions29 Jul 2004US 2004/0146892 A1
Most cited
By later US patents
- Compounds and methods for treating mitochondria-associated diseases123US 6,268,398 B12001
- Methods for detecting mitochondrial mutations diagnostic for Alzheimer's disease and methods for determining heteroplasmy of mitochondrial nucleic acid118US 5,976,798 A1999
- Screening assays using intramitochondrial calcium82US 6,808,873 B22004
- Method of targeting conjugate molecules to mitochondria72US 6,171,859 B22001
- Cytochrome oxidase mutations aiding diagnosis of sporadic alzheimer's disease37US 5,565,323 A1996